COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,015 Articles (22,627 medRxiv, 8,388 bioRxiv)

Most recent first Previous |  Page 2120: Articles 21191-21200  | Next

Structural basis for the inhibition of the SARS-CoV-2 RNA-dependent RNA polymerase by favipiravir-RTP
Naydenova, K., Muir, K. W., Wu, L.-F., Zhang, Z., Coscia, F., Peet, M. J., Castro-Hartmann, P., Qian, P., Sader, K., Dent, K., Kimanius, D., Sutherland, J. D., Lowe, J., Barford, D., Russo, C. J.
10.1101/2020.10.21.347690 — Posted: 2020-10-21
Preclinical study of DNA vaccines targeting SARS-CoV-2
Hayashi, H., Sun, J., Yanagida, Y., Otera, T., Kubota-Kotetsu, R., Shioda, T., Ono, C., Matsuura, Y., Arase, H., Yoshida, S., Nakamaru, R., Ide, R., Tenma, A., Kawabata, S., Ehara, T., Sakaguchi, M., Tomioka, H., Shimamura, M., Okamoto, S., Amaishi, Y., Chono, H., Mineno, J., Komatsuno, T., Saito, Y., Rakugi, H., Morishita, R., Nakagami, H.
10.1101/2020.10.21.347799 — Posted: 2020-10-21
Validation of expert system enhanced deep learning algorithm for automated screening for COVID-Pneumonia on chest X-rays
Gidde, P. S., Prasad, S. S., Singh, A. P., Batheja, N., Prakash, S., Singh, P., Saboo, A., Thakar, R., Gupta, S., Saurav, S., Raghunandan, M. V., Singh, A., Sardana, V., Mahajan, H., Kalyanpur, A., Mandal, A. S., Mahajan, V., Agrawal, A., Agrawal, A., Venugopal, V. K., Singh, S., Dash, D.
10.1101/2020.10.20.20213793 — Posted: 2020-10-21
Analytical evaluation and critical appraisal of early commercial SARS-CoV-2 immunoassays for routine use in a diagnostic laboratory.
Cramer, A., Goodman, N., Cross, T., Gant, V. A., Dziadzio, M.
10.1101/2020.10.20.20215970 — Posted: 2020-10-21
Epidemic Curve of Contamination in a Hospital That Served as Sentinel of the Spread of the SARS-Cov-2 Epidemic in the City of Rio de Janeiro
Santos, M., Guimaraes, T. F., Rey, H. C., Mucillo, F., Carvalho, A., Bezerra, I., Barbosa, R., Brunswick, T. H. K., Dias, G. M., Issa, A., Carvalho, A. C. C. d.
10.1101/2020.10.19.20215079 — Posted: 2020-10-21
Cognitive deficits in people who have recovered from COVID-19 relative to controls: An N=84,285 online study
Hampshire, A., Trender, W., Chamberlain, S., Jolly, A., Grant, J. E., Patrick, F., Mazibuko, N., Williams, S., Barnby, J. M., Hellyer, P., Mehta, M. A.
10.1101/2020.10.20.20215863 — Posted: 2020-10-21 Discussion: Onsite
Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance
Le Vu, S., Jones, G., Anna, F., Rose, T., Richard, J.-B., Bernard-Stoecklin, S., Goyard, S., Demeret, C., Helynck, O., Robin, C., Monnet, V., Perrin de Facci, L., Ungeheuer, M.-N., Leon, L., Guillois, Y., Filleul, L., Charneau, P., Levy-Bruhl, D., van der Werf, S., Noel, H.
10.1101/2020.10.20.20213116 — Posted: 2020-10-21
Prevalence of SARS-CoV-2 IgG antibodies in a population from Veracruz (Southeastern Mexico).
Remes-Troche, J. M., Ramos-de-la-Medina, A., Manriquez-Reyes, M., Martinez-Perez Maldonado, L., Solis-Gonzalez, M. A., Hernandez-Flores, K., Vivanco-Cid, H.
10.1101/2020.10.19.20215558 — Posted: 2020-10-21
Tocilizumab is associated with reduction in inflammation and improvement in P/F ratio in critically sick COVID19 patients
Rana, M. A., Hashmi, M. S., Saif, M. M. U., Munir, M. F., Qayyum, A., Pervaiz, R., Hafeez, M. M.
10.1101/2020.10.20.20210195 — Posted: 2020-10-21
Characteristics and outcomes of clinically diagnosed RT-PCR swab negative COVID-19: a retrospective cohort study
Middleton, P., Perez-Guzman, P. N., Cheng, A., Kumar, N., Kont, M., Daunt, A., Mukherjee, S., Cooke, G., Hallett, T. B., Hauck, K. D., White, P. J., Thursz, M. R., Nayagam, S.
10.1101/2020.10.20.20204651 — Posted: 2020-10-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).